Disc Medicine Appoints William White to its Board of Directors News provided by Share this article Share this article CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/ -- Disc Medicine, a biotechnology company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced that it has appointed William White to its Board of Directors. "We are delighted to welcome Bill to Disc Medicine's Board of Directors," said Chief Executive Officer John Quisel, JD, PhD. "Bill is joining at an exciting time in our company's story as ...